Goodpasture syndrome

95,725views

Goodpasture syndrome

Joana

Joana

Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Diabetes insipidus
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Diabetes mellitus: Clinical
Hypertriglyceridemia
Anatomy of the thyroid and parathyroid glands
Insulins
Diabetes mellitus
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Congenital adrenal hyperplasia
Adrenal gland histology
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Esophageal cancer
Gastric cancer
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Peptic ulcers and stomach cancer: Clinical
Colorectal cancer
Colorectal cancer: Clinical
Metaplasia and dysplasia
Diabetic nephropathy
Benign liver tumors
Hepatocellular carcinoma
Peptic ulcer
Peptic ulcer
Helicobacter pylori
Cirrhosis
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Gallbladder carcinoma
Wilson disease
Pancreatic cancer
Carcinoid syndrome
Acromegaly
Viral hepatitis
Hyperthyroidism: Clinical
Alcohol-associated liver disease
Non-alcoholic fatty liver disease
Pituitary adenoma
Non-steroidal anti-inflammatory drugs
Diarrhea: Clinical
Metabolic acidosis
Metabolic alkalosis
Ulcerative colitis
Crohn disease
Respiratory acidosis
Nephrotic syndromes: Pathology review
Goodpasture syndrome
Nephritic syndromes: Pathology review
Respiratory alkalosis
Cholestatic liver disease
Laxatives and cathartics
Polycystic ovary syndrome
MEN syndromes: Clinical
Autoimmune polyglandular syndrome type 1 (NORD)
Type I and type II errors
Gastroesophageal reflux disease (GERD)
Celiac disease
Polycystic kidney disease
Chronic kidney disease
Acute kidney injury: Clinical
IgA nephropathy (NORD)
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Chronic kidney disease: Clinical
Cytomegalovirus infection after transplant (NORD)
Hyperkalemia: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Portal hypertension
Cirrhosis: Clinical
Hypercholesterolemia: Clinical
Gallbladder histology
Chronic cholecystitis
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Macrocytic anemia: Pathology review
Alpha-thalassemia
Beta-thalassemia
Anemia: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Aplastic anemia
Von Willebrand disease
Acute leukemia
Lung cancer: Clinical
Lung cancer
Breast cancer: Clinical
Breast cancer
Monoclonal antibodies
Atrioventricular block
Heart blocks: Pathology review
Abnormal heart sounds
Heart failure
Pulmonary embolism
Pulmonary edema
Pulmonary valve disease
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Innate immune system
Introduction to the immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Type I hypersensitivity
Food allergy
Anaphylaxis
Asthma
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Graft-versus-host disease
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
ELISA (Enzyme-linked immunosorbent assay)
Gel electrophoresis and genetic testing
Fluorescence in situ hybridization
Precipitation reactions
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
Blood groups and transfusions
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Chronic granulomatous disease
Complement deficiency
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
DiGeorge syndrome
X-linked agammaglobulinemia
Hyper IgM syndrome
Leukocyte adhesion deficiency
Immunodeficiencies: Clinical
HIV (AIDS)
Cell-cell junctions
Hashimoto thyroiditis
Wiskott-Aldrich syndrome
Food allergies and EpiPens: Information for patients and families (The Primary School)
Vaccinations: Clinical
Blood products and transfusion: Clinical
Hypersensitivity skin reactions: Clinical
Shock: Clinical
Rheumatic heart disease
Immune thrombocytopenia
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Multiple sclerosis

Flashcards

Goodpasture syndrome

0 of 12 complete

Transcript

Watch video only

Goodpasture syndrome is an autoimmune disease that primarily affects two organs - the lungs and the kidneys.

It causes inflammation and eventually bleeding in the lungs which leads to ‘hemoptysis’ or coughing up of blood, and hematuria or blood in the urine, a pattern first recognized by the pathologist - Dr. Ernest Goodpasture.

To understand Goodpasture syndrome, let’s start by thinking about the basement membrane which is a thin, sheet-like layer of tissue made of protein that keeps the epithelium stuck firmly to actual organ - a bit like double-sided tape which keeps gift wrapping paper stuck to the gift.

The basement membrane is made up of various proteins, but the major one is collagen, and since basement membrane exists throughout every organ system, it’s no wonder that collagen is the most abundant protein in the human body.

As far as proteins go, collagen is a pretty awesome looking one, with a triple-helix structure composed of three separate chains that are intertwined like braided hair.

Each of the chains can be one of six types, named α1 through α6, and the most common form of collagen found in the basement membrane is collagen type IV, which is made by mixing and matching these six α-chains.

One version of type IV collagen combines the α3, α4, and α5 chains. Another combines two α1’s and an α2. A third version has two α5’s and an α6. And so on.

So it turns out that the α3/α4/α5 variant is most common in the glomerular basement membrane of the kidneys and the alveolar basement membrane of the lungs.

In Goodpasture syndrome, autoantibodies bind to a specific part of the α3 chain that is usually hidden deep within the folded chains.

This is an example of a type II hypersensitivity reaction, because once these autoantibodies, usually IgG but rarely IgM or IgA, bind to the the α3 chain, they activate the complement system. The complement system is a series of small proteins present in the blood that act like an enzymatic cascade to fight off bacterial and other pathogenic invasions.

When the Fab portion of the IgG molecule inappropriately binds to the α3 chain, C1, the first of the complement proteins, binds to the Fc portion of the IgG. This bound C1 is now activated and it starts engaging other members of the complement family, C2 through C9.

Some of these are activated by being cleaved or chopped by an enzyme. The cleaved fragments C3a, C4a, and C5a act as chemotactic agents meaning they attract certain cells like neutrophils.

Once neutrophils join the party, they dump a bunch of enzymes like peroxidase, myeloperoxidase, and proteinase-3 which all cause free oxygen radicals to form which damage the basement membrane as well as the nearby endothelium and the underlying organ itself.

Genetic risk factors for Goodpasture syndrome include having genes that encode a specific type of immune molecule called HLA-DR15 which is used to identify and bind to foreign molecules.

Key Takeaways

Goodpasture's syndrome is a rare autoimmune disease in which antibodies attack the basement membrane in lungs and kidneys, leading to bleeding from the lungs and kidney failure. It is thought to attack the alpha-3 subunit of type IV collagen, which has therefore been referred to as Goodpasture's antigen.